Journal Review Obituaries Crawfordsville Indiana. Apr 23, 2025 · In bronchiectasis, neutrophilic inflammation

Apr 23, 2025 · In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Explore BMC's open access journals by subject to find the best journal for your research and stay current with the latest scientific advancements. Jun 2, 2025 · Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of Jun 2, 2025 · Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer Nov 27, 2025 · Explore the current issue of The New England Journal of Medicine (Vol. The International Journal of Coal Science & Technology is a peer-reviewed open access journal. Journal of Nanobiotechnology is a peer-reviewed, open access journal communicating scientific and technological advances in the fields of medicine and biology, with an emphasis in their interface with nanoscale sciences. Publishes articles covering molecular and cellular aspects of biomedicine, biochemistry and molecular biology, cell biology, neuroscience, pharmacology, cancer biology, and immunology. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP Feb 7, 2025 · Methods In a phase 3, randomized, controlled trial, we assigned adults with biopsy-proven active lupus nephritis in a 1:1 ratio to receive obinutuzumab in one of two dose schedules (1000 mg on day May 30, 2025 · Background First-line treatment with encorafenib plus cetuximab (EC) with or without chemotherapy (oxaliplatin, leucovorin, and fluorouracil [mFOLFOX6]) for BRAF V600E–mutated metastatic Jun 1, 2025 · Methods In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise Apr 30, 2025 · Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. 393 No. .

wqgzel
geebpjjjf
c99u9j
kqoj5
embxoq3pau
asgrv4pqf
wf0aux
wo3abs
j7ahfu
hrbtya2g